ESC Premium Access

Inflammation, diabetes and their influence on the heart

Event: ESC CONGRESS 2017
Topic: Drug therapy
Session type: Moderated Posters
Date: 27 August 2017
Time: 10:05 - 10:55


7 presentations in this session

The effect of apabetalone on attenuated coronary atherosclerotic plaque: insights from the ASSURE trial.

Speaker: Doctor D. Shishikura (Melbourne, AU)

Recombinant insulin-like growth factor-1 improves cardiac function and symptoms in the patients on the waiting list for heart transplantation with end-stage dilated cardiomyopathy

Speaker: Professor K. Komamura (Atami, JP)

Direct ugmentation of cholesterol efflux capacity in AMI atients: a PKPD substudy of AEGIS-I

Speaker: Ms M. Yee (Boston, US)

Metformin epigenetically regulates tissue factor expression in diabetes

Speaker: Doctor M. Witkowski (Berlin, DE)

Effects of Tofogliflozin, an Sodium-glucose co-transporter 2 Inhibitor, on Cardiac Hypertrophy in Metabolic Model Rats

Speaker: Doctor T. Kimura (Fukuyama, JP)

Effect of TNF-a antagonists on wave reflections: a meta-analysis.

Speaker: Doctor D. Terentes-Printzios (Athens, GR)

Protective Effect of Immunosuppressor FTY720 against CVB3 Induced-Viral Myocarditis

Speaker: Mr T. Liu (Beijing, CN)

7 speakers from this session

Doctor Daisuke Shishikura

Northern Hospital, Melbourne (Australia)
0 follower

Professor Kazuo Komamura

IUHW Atami Hospital, Atami (Japan)
0 follower

Ms Megan Yee

, Boston (United States of America)
0 follower

Doctor Marco Witkowski

Charite - Campus Benjamin Franklin, Berlin (Germany)
0 follower

Doctor Tomonari Kimura

Fukuyama Cardiovascular Hospital, Fukuyama (Japan)
0 follower

Doctor Dimitrios Terentes-Printzios

National & Kapodistrian University of Athens, Athens (Greece)
1 presentation
0 follower

Mr Tian-Long Liu

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (China)
0 follower

This platform is supported by

logo Novo Nordisk